Abbvie (ABBV) P/B (2013 - 2026)
Abbvie (ABBV) P/B from Jan 2, 2013 to Jul 21, 2026. The TTM Abbvie (ABBV) P/B is -68.12. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/B
Annual P/B change of Abbvie (ABBV)
| Year | P/B | Change |
|---|---|---|
| 2026 | -68.12 | -44.89% |
| 2025 | -123.61 | -230.74% |
| 2024 | 94.54 | +317.55% |
| 2023 | 22.64 | +26.53% |
| 2022 | 17.89 | +15.05% |
| 2021 | 15.55 | +7.30% |
| 2020 | 14.50 | -190.34% |
| 2019 | -16.05 | -2.71% |
| 2018 | -16.49 | -171.41% |
| 2017 | 23.10 | +46.20% |
| 2016 | 15.80 | -36.32% |
| 2015 | 24.81 | -58.60% |
| 2014 | 59.92 | +220.54% |
| 2013 | 18.69 | N/A |
Comparison Abbvie (ABBV) P/B with competitors
Abbvie (ABBV) P/B is -68.12.
| Ticker | Name | P/B | Upside |
|---|---|---|---|
| AMRN | Amarin Corp | 0.68 | -101.00% |
| GRFS | Grifols SA | 0.79 | -101.16% |
| SNY | Sanofi | 1.27 | -101.86% |
| BIIB | Biogen Inc | 1.52 | -102.23% |
| PFE | Pfizer Inc | 1.55 | -102.27% |
| OGN | Organon & Company | 3.93 | -105.76% |
| MIRA | Mira Pharmaceuticals Inc | 4.09 | -106.01% |
| GSK | GSK Plc | 4.37 | -106.42% |
| BMY | Bristol-Myers Squibb Company | 6.04 | -108.87% |
| AZN | Astrazeneca plc | 6.20 | -109.10% |
| MRK | Merck & Co Inc | 6.68 | -109.81% |
| GILD | Gilead Sciences Inc | 6.94 | -110.19% |
| NVO | Novo Nordisk | 7.07 | -110.38% |
| NVS | Novartis AG | 7.60 | -111.16% |
| JNJ | Johnson & Johnson | 7.64 | -111.21% |
| NSRX | Nasus Pharma Ltd | 12.90 | -118.94% |
| MDCX | MDCorp | 15.34 | -122.52% |
| AMGN | AMGEN Inc | 21.17 | -131.08% |
| SCLX | Scilex Holding Company | 28.85 | -142.35% |
| LLY | Lilly(Eli) & Company | 32.94 | -148.35% |